Alcon Laboratories Wins the ASSOCHAM Medical Technology Excellence Awards

admin
admin
· 2 min read
Alcon Laboratories ASSOCHAM Medical Technology Excellence Awards

Alcon, the global leader in eye care, a division of Novartis, has won the prestigious Associated Chambers of Commerce and Industry of India (ASSOCHAM) Medical Technology Excellence Award in two categories, Best Technology Solution in Surgical and Best Technology Solution in Ophthalmology. Shri Y S Chowdhary, Hon’ble Minister of State for Science & Technology and Earth Sciences, Government of India presented the Award to Alcon India in a glittering ceremony held in New Delhi.

The event honoured Alcon India for its contribution in the medical technology in India. The awards were presented in the categories of best technology solution in Medical Imaging, Diagnostic, Monitoring, Surgical, Therapeutic, Radiology, Cardiology, Dermatology, Oncology, Dentistry, Ophthalmology and start up.

Speaking on this occasion, Sandeep Bothra, Country Business Head (Surgical), said, “This award reiterates Alcon’s leadership position in eye care. Our contribution in the medical technology in India, through our innovative products has automated some of the most critical steps in cataract surgery making it safer and more precise. It is a testimony of our efforts to offer the broadest portfolio of products to enhance sight and improve people’s lives.”

ASSOCHAM is a very prestigious and leading trade association of India. Established in 1920 and having more than 4, 50,000 members. It is also referred to as the “Chamber of Chambers” having in its fold more than 400 Industry Chambers.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk